A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.

Dampier CD, Telen MJ, Wun T, Brown RC, Desai P, El Rassi F, Fuh B, Kanter J, Pastore Y, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray H, Magnani JL, Hassell KL. A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood. 2023 01 12; 141(2):168-179.

View in: PubMed

subject areas

Adult
Analgesics, Opioid
Anemia, Sickle Cell
Child
Double-Blind Method
E-Selectin
Hemoglobinopathies
Humans
Pain
Volatile Organic Compounds

authors with profiles

James Taylor

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support